Filing Flows › Health Care › Cardiff Lexington (CDIX)
Cardiff Lexington (CDIX) earnings and revenue breakdown
Latest: Q2 2026 · 10-Q filed Aug 12, 2026 · Cardiff Lexington (CDIX) Q2 2026 earnings results →
Q2 2026 Revenue down 23% year over year to $2.2M · 115¢ of every $1 of revenue lost · operating margin -25.2%
Cardiff Lexington made $2.2M in Q2 2026 (-23% Y/Y). Operating margin -25.2%, net loss $2.5M. See where every dollar goes — costs, profit and cash — as a Sankey from the 10-Q filed Aug 12, 2026.
Drawing the Sankey…
Open the interactive Sankey → click any line for what the company wrote about it, compare Y/Y and Q/Q, export as PNG or PDF
What changed this quarter
Revenue was $2.2M in Q2 2026, down 23% year over year and down 3% from the previous quarter.
Gross margin was 54.7%, down 6.0 points from Q2 2025. Operating costs exceeded revenue by $545K, an operating margin of -25.2%. Operating expenses grew 59% against a revenue fall of 23%. The fastest-growing cost line was Other operating costs (+274%). The quarter ended with a net loss of $2.5M, narrower than the previous quarter's $3.1M loss. Net interest and other expense of $1.9M was the main reason.
Operating cash flow was −$652K. Non-cash charges added back $0K of depreciation and $367K of share-based compensation. Working capital and other items added $1.5M.
Quarterly history
| Quarter | Form | Filed | Revenue | Y/Y | Op. margin | Net earnings | Op. cash flow |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 10-Q | Aug 12, 2026 | $2.2M | -23% | -25.2% | −$2.5M | −$652K |
| Q1 2026 | 10-Q | May 13, 2026 | $2.2M | -24% | -23.0% | −$3.1M | −$17K |
| Q4 2025 | 10-K | Mar 10, 2026 | $2.8M | -11% | -25.1% | −$2.7M | −$390K |
| Q3 2025 | 10-Q | Nov 12, 2025 | $3.1M | +126% | 21.0% | −$1.1M | −$574K |
| Q2 2025 | 10-Q | Aug 19, 2025 | $2.8M | +90% | 21.9% | −$1.2M | −$1.4M |
| Q1 2025 | 10-Q | May 9, 2025 | $2.9M | +26% | 18.7% | −$451K | −$491K |
| Q4 2024 | 10-K | Mar 14, 2025 | $3.1M | +31% | 10.6% | −$910K | −$1.9M |
Charts
Interactive views
The same charts as the app — open one to draw it.
💵Where each $1 goesinteractive
Loading the interactive chart…
🌏Named in Asian annual reportsinteractive
Loading the interactive chart…
🔄Rotation against the market and its industry (RRG)interactive
Loading the interactive chart…
🔍Earnings qualityinteractive
Loading the interactive chart…
⚖️Fair value by methodinteractive
Loading the interactive chart…
🔭Outlook & guidanceinteractive
Loading the interactive chart…
📈Investments: gains and what it boughtinteractive
Loading the interactive chart…
🏭Its industry’s money flow (input-output)interactive
Loading the interactive chart…
Cardiff Lexington against its Services-Offices & Clinics of Doctors of Medicine peers
The largest companies of the same SEC industry, each at its latest quarter. Revenue growth: -23% against the peers' median -3%. Operating margin: -25.2% against the peers' median -12.9%.
| Company | Quarter | Revenue | Y/Y | Op. margin |
|---|---|---|---|---|
| CDIX Cardiff Lexington | Q2 2026 | $2.2M | -23% | -25.2% |
| HIMS Hims & Hers Health | Q2 2026 | $753M | +38% | -12.9% |
| TDOC Teladoc Health | Q3 2026 | $605M | -3% | -4.6% |
| STLN Starling Oncology | Q3 2026 | $170M | +24% | -1.8% |
| SBC SBC Medical Group Holdings | Q2 2026 | $49.2M | +13% | 38.5% |
| LFMD LifeMD | Q2 2026 | $47.3M | -4% | -15.1% |
| AIRS Airsculpt Technologies | Q3 2026 | $31.9M | -9% | -13.0% |
| HLYK HealthLynked | Q2 2026 | $250K | -58% | -215.7% |
Source: Cardiff Lexington 10-Q on SEC EDGAR · CIK 811222 · Services-Offices & Clinics of Doctors of Medicine
More on CDIX
History
Every quarter: Q2 2026 results · Q1 2026 results · Q4 2025 results · Q3 2025 results · Q2 2025 results · Q1 2025 results · Q4 2024 results